Mars is buying some of Procter & Gamble's pet food brands for $2.9 billion to help strengthen its pet care business.
Mallinckrodt is buying California-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business.
Nokia has received regulatory approval from Chinese authorities to sell its mobile phone unit to Microsoft Corp., removing one of the last major hurdles to the $7.3 billion deal.
Private equity firm The Blackstone Group will buy industrial products maker Gates Corp. for $5.4 billion, according to Gates' owners.
The Cleveland-based paint company had agreed in 2012 to buy Consorcio Comex in a deal valued at $2.34 billion, including debt, to increase its presence in certain markets.
Two of the world's largest suppliers of building materials announced plans for a "merger of equals" Monday that would create an industry giant with a combined 32 billion euros ($44 billion) in annual revenues.
India's Sun Pharmaceutical Industries is buying troubled generic drug maker Ranbaxy Laboratories in a $4 billion deal, the companies said Monday.
A small group of Milwaukee residents wants to revive part of that proud history by buying Pabst Brewing Co. from a California executive in hopes of returning the brand to its birthplace, possibly as a city-owned brewery.
Solid Concepts Inc. is the biggest independent additive manufacturing service bureau in North America and a partner to RedEye, Stratasys' existing digital manufacturing service business.
Drug maker Actavis Plc plans to expand its reach into Southeast Asia by spending about $100 million to buy Silom Medical Co., a generic pharmaceutical company focused on Thailand.
Daimler AG is acquiring the remaining shares in a lithium-ion battery cell maker from specialty chemical company Evonik Industries AG as it intensifies its focus on electric cars.
Johnson & Johnson has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business.
Marchionne said the merged company will be able to increase production to more than 6 million cars a year, a level he has long said is the minimum for an automaker to compete in the global market.
Beyond games, Zuckerberg said virtual reality headsets might someday be used to enjoy a courtside seat at a basketball game, study in a classroom, consult with a doctor face-to-face or shop in a virtual store. The technology also has social applications, he said.
California-based Fisker planned to build cars at the former General Motors plant, but it filed for bankruptcy protection in November.
Nokia Corp. says the $7.3 billion deal will be delayed until next month because it is still waiting for approval from regulatory authorities in Asia.
Horizon Pharma plans to buy Vidara Therapeutics International in a cash-and-stock deal that will add the immune system disorder drug Actimmune to the specialty drug maker's product portfolio.
The company said it would preserve the Beechcraft, Cessna and Hawker general-aviation brands under Cessna CEO Scott Ernest.
Fruit supply companies Chiquita of the United States and Fyffes of Ireland said Monday they had agreed to merge to create the world's biggest banana supplier.
British consumer goods company Reckitt Benckiser is buying K-Y personal lubricants from U.S. health care giant Johnson & Johnson.
Flush with cash and high stock prices, companies are buying up the competition at levels not seen since the dotcom bubble.
Mattel Inc. has made a friendly takeover offer for Canadian toy maker Mega Brands Inc., which has the world's No. 2 line of construction sets after Lego.
Minerals Technologies Inc. has sweetened its offer to buy out Amcol International Corp. to about $1.38 billion in hopes the minerals and oilfield services company will be persuaded to nix its proposed sale to a French company.
Chip maker RF Micro Devices Inc. and TriQuint Semiconductor Inc. are combining in an all-stock deal valued at about $1.56 billion. The deal announced Monday represents an implied price of $9.73 for each TriQuint share. This is a 5 percent premium to the company's Friday closing price of $9.23.
Eli Lilly is buying a privately held, poultry vaccine maker to strengthen its Elanco animal health subsidiary. No terms were released, but Lilly said Monday that its 2014 earnings forecast will be trimmed due to acquisition costs.